Acute Myelogenous Leukemia (häftad, eng)

This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities.

There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas.